Helicobacter pylori strains used in this study
Strain1-150 no. | Protein secretion | Vacuolating assay | Type1-151 | ||||
---|---|---|---|---|---|---|---|
VacA | CagA | ||||||
Gastric ulcer | |||||||
1 | (T-1) | + | + | + | I | ||
2 | (T-6) | + | + | + | I | ||
3 | (T-24) | + | + | + | I | ||
4 | (T-39) | + | + | + | I | ||
5 | (T-72) | + | + | + | I | ||
6 | (T-84) | + | + | + | I | ||
7 | (T-97) | + | + | + | I | ||
8 | (T-23) | + | + | + | I | ||
9 | (T-59) | + | + | + | I | ||
10 | (T-78) | + | + | + | I | ||
11 | (T-99) | + | + | + | I | ||
12 | (T-48) | − | + | + | I | ||
13 | (T-87) | − | + | + | I | ||
14 | (T-79) | + | + | − | Intermediate | ||
15 | (T-98) | + | + | − | Intermediate | ||
16 | (T-57) | + | − | − | Intermediate | ||
Duodenal ulcer | |||||||
17 | (T-10) | + | + | + | I | ||
18 | (T-29) | + | + | + | I | ||
19 | (T-54) | + | + | + | I | ||
20 | (T-56) | + | + | + | I | ||
21 | (T-60) | + | + | + | I | ||
22 | (T-71) | + | + | + | I | ||
23 | (T-74) | + | + | + | I | ||
24 | (T-92) | + | + | + | I | ||
25 | (T-101) | + | + | + | I | ||
26 | (T-9) | + | + | + | I | ||
27 | (T-13) | + | + | + | I | ||
28 | (T-35) | + | + | + | I | ||
29 | (T-63) | + | + | + | I | ||
30 | (T-82) | + | + | + | I | ||
31 | (T-12) | − | − | + | Intermediate | ||
32 | (T-64) | + | − | − | Intermediate | ||
33 | (T-15) | − | + | − | Intermediate | ||
Non-ulcer dyspepsia | |||||||
34 | (T-5) | + | + | + | I | ||
35 | (T-11) | + | + | + | I | ||
36 | (T-17) | + | + | + | I | ||
37 | (T-61) | + | + | + | I | ||
38 | (T-75) | + | + | + | I | ||
39 | (T-76) | + | + | + | I | ||
40 | (T-77) | + | + | + | I | ||
41 | (T-80) | + | + | + | I | ||
42 | (T-89) | + | + | + | I | ||
43 | (T-90) | + | + | + | I | ||
44 | (T-111) | + | + | + | I | ||
45 | (T-16) | + | + | + | I | ||
46 | (T-73) | + | + | + | I | ||
47 | (T-88) | + | + | + | I | ||
48 | (T-93) | + | + | + | I | ||
49 | (T-100) | + | + | + | I | ||
50 | (T-102) | + | + | + | I | ||
51 | (T-103) | + | + | + | I | ||
52 | (T-94) | + | − | + | Intermediate | ||
53 | (T-53) | + | − | + | Intermediate | ||
54 | (T-47) | + | + | − | Intermediate | ||
55 | (T-3) | − | + | − | Intermediate | ||
56 | (T-25) | − | − | − | II | ||
57 | (T-85) | − | − | − | II | ||
58 | (T-68) | − | − | − | II | ||
Gastric cancer | |||||||
59 | (T-7) | + | + | + | I | ||
60 | (T-115) | + | + | + | I | ||
61 | (T-116) | + | + | + | I | ||
62 | (T-22) | + | + | + | I | ||
63 | (T-26) | + | + | + | I | ||
64 | (T-81) | + | + | + | I | ||
65 | (T-112) | + | + | + | I | ||
66 | (T-113) | + | + | + | I | ||
67 | (T-114) | + | + | + | I | ||
68 | (T-108) | − | + | − | Intermediate | ||
Controls | |||||||
69 | (43526) | + | + | + | |||
70 | (Tx30a) | + | − | − |
↵1-150 The strains whose designation starts with a T were isolated at Tokyo University Hospital. 43526 was ATCC 43526 from American Type Culture Collection and Tx30a was from Texas.
↵1-151 Type I strains were positive for vacuolating activity and CagA protein. Type II strains were negative for both, and intermediate strains belonged to neither Type I nor Type II.